Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Fuchs

Showing results (21-30 of 257) with videos related to

Pageof 26
Sort By:
The Journal of Antimicrobial Chemotherapy|January 1, 1989
Activity of cefepime (BMY-28142) and cefpirome (HR 810) against gram-negative bacilli resistant to cefotaxime or ceftazidimeR N Jones, P C Fuchs
Antimicrobial Agents and Chemotherapy|May 1, 1991
In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacinA L Barry, P C Fuchs
The Journal of Antimicrobial Chemotherapy|February 1, 1991
In-vitro activity of four penicillin/beta-lactamase inhibitor combinations against cefoxitin-susceptible and cefoxitin-resistant Bacteroides fragilis isolatesA L Barry, P C Fuchs
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 1, 1991
Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacinA L Barry, P C Fuchs
Antimicrobial Agents and Chemotherapy|June 1, 1991
In vitro susceptibility testing procedures for fosfomycin tromethamineA L Barry, P C Fuchs
The Journal of Reproductive Medicine|March 1, 1990
Implications of beta-lactamase-inhibitor combinationsP C Fuchs, A L Barry
The Journal of Antimicrobial Chemotherapy|July 1, 1996
Are ciprofloxacin susceptibility tests relevant for Streptococcus pneumoniae?A L Barry, P C Fuchs
The Journal of Antimicrobial Chemotherapy|November 1, 1991
Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacinA L Barry, P C Fuchs
Antimicrobial Agents and Chemotherapy|July 1, 1976
In vitro antimicrobial activity of cinoxacin against 2,968 clinical bacterial isolatesR N Jones, P C Fuchs
Journal of Chemotherapy (Florence, Italy)|February 1, 1997
Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacinA L Barry, P C Fuchs
Pageof 26

Showing results (21-30 of 257) with videos related to

Sort By:
Pageof 26
The Journal of Antimicrobial Chemotherapy|January 1, 1989
Activity of cefepime (BMY-28142) and cefpirome (HR 810) against gram-negative bacilli resistant to cefotaxime or ceftazidimeR N Jones, P C Fuchs
Antimicrobial Agents and Chemotherapy|May 1, 1991
In vitro activities of sparfloxacin, tosufloxacin, ciprofloxacin, and fleroxacinA L Barry, P C Fuchs
The Journal of Antimicrobial Chemotherapy|February 1, 1991
In-vitro activity of four penicillin/beta-lactamase inhibitor combinations against cefoxitin-susceptible and cefoxitin-resistant Bacteroides fragilis isolatesA L Barry, P C Fuchs
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 1, 1991
Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacinA L Barry, P C Fuchs
Antimicrobial Agents and Chemotherapy|June 1, 1991
In vitro susceptibility testing procedures for fosfomycin tromethamineA L Barry, P C Fuchs
The Journal of Reproductive Medicine|March 1, 1990
Implications of beta-lactamase-inhibitor combinationsP C Fuchs, A L Barry
The Journal of Antimicrobial Chemotherapy|July 1, 1996
Are ciprofloxacin susceptibility tests relevant for Streptococcus pneumoniae?A L Barry, P C Fuchs
The Journal of Antimicrobial Chemotherapy|November 1, 1991
Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacinA L Barry, P C Fuchs
Antimicrobial Agents and Chemotherapy|July 1, 1976
In vitro antimicrobial activity of cinoxacin against 2,968 clinical bacterial isolatesR N Jones, P C Fuchs
Journal of Chemotherapy (Florence, Italy)|February 1, 1997
Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacinA L Barry, P C Fuchs
Pageof 26